Where biotech companies are betting on AI.
Six use cases driving measurable productivity and growth across the biotech R&D, clinical and commercial value chain.
Target discovery
Agents mine omics, literature and assay data to nominate targets and design candidate molecules, compressing hit-to-lead cycles.
30 to 50% faster hit-to-lead
Trial design and recruitment
Agents match patients to protocols from EHR and registry data, model site feasibility and stress-test inclusion criteria.
25 to 40% faster enrollment
Regulatory and medical writing
Agents draft INDs, CSRs and safety narratives from source data with traceable citations, so authors review rather than write.
40 to 60% less drafting time
Lab automation
Self-driving lab agents plan assays, orchestrate instruments and triage results, closing the design-make-test-analyze loop.
2 to 3x experiments per scientist
Manufacturing and quality
Models predict batch deviations, tune bioprocess parameters live and auto-draft deviation and CAPA documentation for QA review.
15 to 25% lower batch failure
Commercial and medical affairs
Agents personalize HCP engagement, synthesize field insights and answer medical information queries at scale with audit trails.
20 to 35% more field capacity
Figures are directional industry benchmarks from 2025 to 2026 biopharma and life sciences AI deployments. We verify against your baseline before they appear in any proposal.
Bring these use cases into your plan.
Thirty minutes with a senior practitioner turns this list into your shortlist. Or start with the free AI Assessment and see where you stand.
Schedule a 30-minute discovery call